The Indian Health Service (IHS), Gallup Service Unit located at 516 E. Nizhoni Blvd., Gallup, New Mexico 87301 is seeking capable sources that can provide molecular diagnostic testing supplies, calibration materials, quality control materials and expendables such as cuvettes, waste containers compatible with the Cepheid Infinity analyzer. Sources must also be capable of providing repair parts, routine preventative maintenance services and support to the Cepheid Infinity analyzer currently located in the facility.
The anticipated period of performance is as follows:
Base Period: April 1, 2024 – March 31, 2025
1st Option Period: April 1, 2025 – March 31, 2026
2nd Option Period: April 1, 2026 – March 31, 2027
3rd Option Period: April 1, 2027 – March 31, 2028
4th Option Period: April 1, 2028 – March 31, 2029
The applicable North American Industry Classification System (NAICS) code assigned to this procurement is 325413, In-Vitro Diagnostic Substance Manufacturing with a small business size standard of 1,250 employees.
The government will evaluate market information to ascertain potential market capacity to provide supplies with those described in this notice.
In accordance with the Buy Indian Act, 25 U.S.C. 47, the Indian Health Service shall give preference at all times, as far as practicable, to Indian economic enterprises. If your firm is capable of providing the supplies and/or services described in this notice, complete the attached representation form and submit it along with the rest of the requested documents identified in this notice.
THE RESPONSES TO THIS SOURCES SOUGHT NOTICE/MARKET RESEARCH WILL BE USED TO DETERMINE THE ACQUISITION STRATEGY SUCH AS INDIAN-OWNED ENTERPRISE SET ASIDES, TOTAL SMALL BUSINESS SET ASIDE, ANY OTHER SOCIO-ECONOMIC SET ASIDE, OR UNRESTRICTED.
NOTE: If this requirement is set-aside, FAR 52.219-14 Limitations on Subcontracting will apply; similarly-situated entity description applies. This clause requires that the concern perform at least 50 percent (50%) of the cost of the contract, not including the cost of materials, with its own employees.
SUBMISSION INSTRUCTIONS:
All interested sources must submit a capabilities package to the primary point of contact listed below, no later than (NLT) February 21, 2024 at 3:00 pm (MST).
AT A MINIMUM, THE FOLLOWING INFORMATION MUST BE SUBMITTED TO THE POC LISTED IN THIS NOTICE:
- Confirm the Buy-Indian set-aside status you qualify for under following NAICS Code: 325413, In-Vitro Diagnostic Substance Manufacturing
- If the proposed NAICS is not the customary or applicable NAICS relative to the needs description, include your firm’s proposed NAICS and rationale for the different NAICS.
- If claiming IEE or ISBEE status, complete and submit the attached IHS Buy Indian Act Indian Economic Enterprise Representation Form.
- If Non-Indian, indicate firm’s size – small or other-than-small; and other socio-economic program participation such as small-disadvantaged, 8(a)-certified, HUBZone, SDVOSB, and/or WOSB/EDWOSB
- A positive statement of your intention to submit a quote to an upcoming solicitation as a prime contractor.
- Provide firm’s UEI Number.
- Evidence of recent (within the last five years) experience with work similar in type and scope to include:
- Contract Numbers
- Project Titles
- Dollar Amounts
- Percent and complete description of work self-performed.
- Customer points of contact with current telephone number and email address.
All of the above information must be submitted in sufficient detail for a decision to be made on availability of interested qualified Buy-Indian parties, or any other type of set aside.
Point of Contact:
Misty Billy, Lead Contract Specialist
Misty.Billy@ihs.gov
Place of Performance:
Gallup Indian Medical Center
516 E. Nizhoni Blvd.
Gallup, New Mexico 87301
THIS IS NOT A SOLICITATION.
